文献速递心境障碍

抑郁症电休克治疗后自杀死亡风险:加拿大倾向评分加权回顾性队列研究

Risk of suicide death following electroconvulsive therapy treatment for depression: a propensity score-weighted, retrospective cohort study in Canada.
PubMed 文献 · Lancet Psychiatry · 2022-04-26

该研究利用加拿大安大略省2007年4月1日至2017年12月31日因抑郁症入住精神科病房超过3天的成人行政健康数据,采用倾向评分加权回顾性队列设计,比较电休克治疗暴露组与非暴露组出院后365天内自杀死亡风险。结果显示电休克治疗与自杀死亡风险显著降低相关(csHR 0.53,95%CI 0.31-0.92),全因死亡率亦显著降低(0.75,0.58-0.97),非自杀死亡无显著差异(0.83,0.61-1.12)。

要点

  • 电休克治疗与出院后365天内自杀死亡风险显著降低相关(csHR 0.53,95%CI 0.31-0.92)。
  • 电休克治疗与全因死亡率显著降低相关(csHR 0.75,95%CI 0.58-0.97)。
  • 非自杀死亡风险无显著差异(csHR 0.83,95%CI 0.61-1.12)。

核心结论

  • 因抑郁症入院患者中,电休克治疗与出院后一年内自杀死亡风险显著降低相关。
  • 该研究强调电休克治疗的重要性,尤其对重度抑郁症患者。

研究设计与样本

  • 倾向评分加权回顾性队列研究,使用加拿大安大略省关联人口水平行政健康数据。
  • 纳入2007年4月1日至2017年12月31日因抑郁症入住指定精神科床位超过3天的成人。
  • 分析队列共67 327条精神科住院记录(27 231名男性,40 096名女性;平均年龄45.1岁,SD 16.8,范围18-103)。
  • 电休克治疗暴露定义为住院期间一次或以上医生计费操作代码,暴露组4 982例,非暴露组62 345例。
  • 主要结局为出院后365天内行政健康记录识别的自杀死亡,采用原因别Cox比例风险模型估计原因别风险比(csHR)。

主要发现

  • 倾向评分加权分析中,电休克治疗与自杀死亡风险显著降低相关(csHR 0.53,95%CI 0.31-0.92)。
  • 将非自杀死亡作为竞争风险纳入后结果无变化。
  • 电休克治疗与全因死亡率显著降低相关(csHR 0.75,95%CI 0.58-0.97)。
  • 电休克治疗与非自杀死亡无显著关联(csHR 0.83,95%CI 0.61-1.12)。

临床怎么用

  • 作者认为该研究强调电休克治疗的重要性,尤其对重度抑郁症患者。

局限性

  • 无种族数据可用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Previous studies examining the risk of suicide death after treatment with electroconvulsive therapy have been confounded and the resulting uncertainty around the risk-benefit profile of electroconvulsive therapy might contribute to its underuse. We aimed to compare the risk of death by suicide after psychiatric hospitalisation among individuals with depression who had been exposed to electroconvulsive therapy with those who had not. METHODS: This was a propensity score-weighted, retrospective cohort study using linked population-level administrative health data for adults with depression who had been admitted to a designated psychiatric bed in Ontario, Canada for more than 3 days between April 1, 2007 and Dec 31, 2017. Electroconvulsive therapy exposure was defined as one or more physician billing procedure codes during hospitalisation. The primary outcome was death by suicide identified using administrative health records within 365 days following discharge. We used cause-specific Cox proportional hazards model to estimate the cause-specific hazard ratio (csHR) for electroconvulsive therapy-exposed and electroconvulsive therapy-unexposed individuals. Secondary outcomes were non-suicide death and all-cause mortality. FINDINGS: In the analytic cohort, there were 67 327 psychiatric hospitalisation records (27 231 men and 40 096 women; mean age 45·1 years [SD 16·8; range 18-103]), of whom 4982 were exposed to electroconvulsive therapy and 62 345 were not exposed to electroconvulsive therapy. No ethnicity data were available. In propensity-score weighted analyses, electroconvulsive therapy was associated with a significantly reduced risk of suicide death (csHR 0·53 [95% CI 0·31-0·92]). Accounting for non-suicide death as a competing risk had no effect on the findings. Electroconvulsive therapy was also associated with a significantly reduced risk of all-cause mortality (0·75 [0·58-0·97]), but not non-suicide death (0·83 [0·61-1·12]). INTERPRETATION: Among individuals admitted to hospital with depression, electroconvulsive therapy is associated with a significantly reduced risk of death by suicide in the year after discharge. This study reinforces the importance of electroconvulsive therapy, particularly for people with severe depression. FUNDING: Norris Scholars Award, Department of Psychiatry, University of Toronto, and the Canadian Institutes for Health Research.

来源:Lancet Psychiatry,查看原文。版权归原作者所有。

引用

  1. Kaster TS, Blumberger DM, Gomes T, et al. Risk of suicide death following electroconvulsive therapy treatment for depression: a propensity score-weighted, retrospective cohort study in Canada. Lancet Psychiatry. 2022. PMID: 35487236. doi:10.1016/S2215-0366(22)00077-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。